Circular RNA vaccines against SARS-CoV-2 and emerging variants
Peking University · Center for Life Sciences · +4 more institutions
Abstract
Vaccine protected against both Delta and Omicron or functioned as a booster after two doses of either native- or Delta-specific vaccination, making it a favorable choice against the current variants of concern (VOCs) of SARS-CoV-2.
Citation impact
- FWCI
- 54.54
- Percentile
- 100%
- References
- 102
Authors
32- LQLiang Qu
Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research
- ZYZongyi Yi
Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research
- YSYong Shen
Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research
- LLLiangru Lin
Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research
- FCFeng Chen
Peking University, Center for Life Sciences, State Key Laboratory of Protein and Plant Gene Research
Topics & keywords
- Biology
- Virology
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- RNA
- 2019-20 coronavirus outbreak
- Genetics
- Computational biology
- Good health and well-being